ccounts payable $621,115 $806,134
Accrued expenses 2,385,540 1,532,170
Preferred dividends payable 25,068 53,025
Total current liabilities 3,031,723 2,391,329
Obligations under capital leases 49,597 23,176
Deferred gain on sale of facilities 836,733 1,074,339
Deferred grant income 203,483 257,245
Total liabilities 4,121,536 3,746,089
Total stockholders' equity 9,709,202 7,447,459
Total liabilities and stockholders' equity $13,830,738 $11,193,548
The Female Health Company
Unaudited Condensed Consolidated Income Statements
For the 3 Months Ended For the 12 Months Ended
September 30, September 30,
2008 2007 2008 2007
Net revenues $7,839,973 $5,174,227 $25,634,126 $19,319,889
Cost of products
sold 4,326,660 3,143,306 14,904,325 12,163,574
Gross profit 3,513,313 2,030,921 10,729,801 7,156,315
Advertising and
promotion 62,455 48,854 223,800 179,874
Selling, general and
administrative 2,138,314 1,527,722 7,038,060 5,864,436
Research and
development 81,975 51,939 284,216 208,608
Total operating
expenses 2,282,744 1,628,515 7,546,076 6,252,918
Operating income 1,230,569 402,406 3,183,725 903,397
Interest income, net
of expense (22,816) (784) (53,445) (36,004)
Foreign currency
transactions (gain)
loss (893,11
'/>"/>SOURCE The Female Health Company Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 Related biology technology :1.
The Female Health Company to Present at Rodman & Renshaw 10th Annual Global Investment Conference2.
The Female Health Company Reports Record Profit for Both Fourth Quarter and Fiscal Year 20073.
Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD)4.
Regado Biosciences to Present at the Piper Jaffray Health Care Conference on Tuesday, December 2, 20085.
Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist6.
Beckman Coulter to Present at Upcoming Healthcare Conferences7.
Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference8.
MannKind to Present at the Piper Jaffray 20th Annual Health Care Conference9.
Sangamo BioSciences to Webcast Annual Investor and Analyst Briefing and Presentation at Piper Jaffray Health Care Conference10.
Celator(R) Pharmaceuticals to Present at Piper Jaffray Health Care Conference and Mid-Atlantic Capital Conference11.
BioMarin to Present at the Piper Jaffray Healthcare Conference